OCD and Psilocybin

Early studies show promising reductions in OCD symptoms, even for people who have not responded to conventional treatment. Benefits may appear rapidly and can last several days, but research is still limited. Larger, controlled trials are needed to understand long term safety, dosing, and effectiveness.

🔎 Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder

🔎Psilocybin for the Treatment of Obsessive-Compulsive Disorders

🔎 Single-dose psilocybin for treatment-resistant obsessive-compulsive disorder: A case report

🔎Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study